Stay updated on LY2880070 in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.

Latest updates to the LY2880070 in Advanced Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded a related publication abstract LY2880070 with gemcitabine in cancer (ASCO 2020), the sponsor Esperas Pharma Inc., and a note for Helpful Links Provided by Esperas Pharma Inc.; to avoid alerts for small changes, set an alert condition below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check32 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference3%

- Check40 days agoChange DetectedNew version tag added (v3.1.0); a significant term, 'Ovarian cancer', was removed from the content, indicating a content focus shift with the release update.SummaryDifference0.1%

- Check54 days agoChange DetectedVersion updated to v3.0.2; removed an old revision tag (v3.0.1), the 'Back to Top' link, and a Helpful Links item about a LY2880070 study.SummaryDifference1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has been updated to include new drug information related to Gemcitabine and additional cancer-related topics, while some previous location details and specific cancer types have been removed.SummaryDifference15%

Stay in the know with updates to LY2880070 in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.